透析公司的投资建议:行业发展趋势如何?

Jiayi Song
{"title":"透析公司的投资建议:行业发展趋势如何?","authors":"Jiayi Song","doi":"10.54254/2754-1169/98/2024ox0109","DOIUrl":null,"url":null,"abstract":"The global dialysis market is continuing expanding in the recent years and dialysis industry has expected investment prospects. This study presents a comprehensive investment analysis framework comparing four top companies in the kidney care and dialysis service industry. This article aims help investor choose the most suitable company among them with the highest investment value to invest in. The study uses official financial data from Nasdaq from 2023 and forecast data from estimates of 2024 of 4 dialysis companies on the waiting list. By analyzing and comparing the financial statements of four companies, the asset investment potential and growth rate of the four companies were determined. Results demonstrate that the company DaVita rank as the most appealing investment option out of four companies, followed by Medtronic, Baxter and Fresenius. Based on financial statements, DaVita is attractive with highest expected growth rates in EPS and gross revenue, PEG ratio, and relatively high annual and quarterly gross margin.","PeriodicalId":104305,"journal":{"name":"Advances in Economics, Management and Political Sciences","volume":"9 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Investment Advice of Dialysis Companies: Whats the Trend of the Industry?\",\"authors\":\"Jiayi Song\",\"doi\":\"10.54254/2754-1169/98/2024ox0109\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The global dialysis market is continuing expanding in the recent years and dialysis industry has expected investment prospects. This study presents a comprehensive investment analysis framework comparing four top companies in the kidney care and dialysis service industry. This article aims help investor choose the most suitable company among them with the highest investment value to invest in. The study uses official financial data from Nasdaq from 2023 and forecast data from estimates of 2024 of 4 dialysis companies on the waiting list. By analyzing and comparing the financial statements of four companies, the asset investment potential and growth rate of the four companies were determined. Results demonstrate that the company DaVita rank as the most appealing investment option out of four companies, followed by Medtronic, Baxter and Fresenius. Based on financial statements, DaVita is attractive with highest expected growth rates in EPS and gross revenue, PEG ratio, and relatively high annual and quarterly gross margin.\",\"PeriodicalId\":104305,\"journal\":{\"name\":\"Advances in Economics, Management and Political Sciences\",\"volume\":\"9 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-26\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in Economics, Management and Political Sciences\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.54254/2754-1169/98/2024ox0109\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Economics, Management and Political Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.54254/2754-1169/98/2024ox0109","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

近年来,全球透析市场持续扩大,透析行业投资前景可期。本研究提出了一个全面的投资分析框架,对肾脏护理和透析服务行业的四家顶级公司进行了比较。本文旨在帮助投资者选择其中最合适、最具投资价值的公司进行投资。本研究使用了纳斯达克 2023 年的官方财务数据和 4 家候选透析公司 2024 年的预测数据。通过分析和比较四家公司的财务报表,确定了四家公司的资产投资潜力和增长率。结果表明,在四家公司中,DaVita 公司是最有吸引力的投资选择,其次是美敦力、百特和费森尤斯。根据财务报表,DaVita 的每股收益和总收入预期增长率最高,PEG 比率最高,年度和季度毛利率相对较高,因此具有吸引力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Investment Advice of Dialysis Companies: Whats the Trend of the Industry?
The global dialysis market is continuing expanding in the recent years and dialysis industry has expected investment prospects. This study presents a comprehensive investment analysis framework comparing four top companies in the kidney care and dialysis service industry. This article aims help investor choose the most suitable company among them with the highest investment value to invest in. The study uses official financial data from Nasdaq from 2023 and forecast data from estimates of 2024 of 4 dialysis companies on the waiting list. By analyzing and comparing the financial statements of four companies, the asset investment potential and growth rate of the four companies were determined. Results demonstrate that the company DaVita rank as the most appealing investment option out of four companies, followed by Medtronic, Baxter and Fresenius. Based on financial statements, DaVita is attractive with highest expected growth rates in EPS and gross revenue, PEG ratio, and relatively high annual and quarterly gross margin.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信